Skip to Main Content

Author Details

Felicia Goodrum
University of Arizona
1996
80
29
PMIDPaper TitleJournal TitlePublished Year
36700640Virology under the Microscope-a Call for Rational Discourse.J Virol2023
37754763Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins.J Virol2023
37819134<i>Journal of Virology</i>-the next generation.J Virol2023
37565749Stabilization of the human cytomegalovirus UL136p33 reactivation determinant overcomes the requirement for UL135 for replication in hematopoietic cells.J Virol2023
37289831Human cytomegalovirus UL138 interaction with USP1 activates STAT1 in infection.PLoS Pathog2023
37338407Liver X Receptor-Inducible Host E3 Ligase IDOL Targets a Human Cytomegalovirus Reactivation Determinant.J Virol2023
37402798Viruses trick bystander cells into lowering their defences.Nature2023
37166327Field Research Is Essential to Counter Virological Threats.J Virol2023
37131605Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins.bioRxiv2023
36519923Virology in Peril and the Greater Risk To Science.mSphere2023
36519890Virology in Peril and the Greater Risk To Science.J Virol2023
36519848Virology in Peril and the Greater Risk To Science.mBio2023
36811614Oversight of Pathogen Research Must Be Carefully Calibrated and Clearly Defined.mSphere2023
36811609Oversight of Pathogen Research Must Be Carefully Calibrated and Clearly Defined.J Virol2023
36747736UL135 and UL136 Epistasis Controls Reactivation of Human Cytomegalovirus.bioRxiv2023
36840577Oversight of Pathogen Research Must Be Carefully Calibrated and Clearly Defined.mBio2023
36798153Human Cytomegalovirus UL138 Interaction with USP1 Activates STAT1 in infection.bioRxiv2023
36897098A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypotheses.mBio2023
36897089A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypotheses.J Virol2023
36897078A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypotheses.mSphere2023
36700653Virology under the Microscope-a Call for Rational Discourse.mSphere2023
36700642Virology under the Microscope-a Call for Rational Discourse.mBio2023
35946797The Akt Forkhead Box O Transcription Factor Axis Regulates Human Cytomegalovirus Replication.mBio2022
35840181The complex biology of human cytomegalovirus latency.Adv Virus Res2022
36541776Recognizing the Top 25 Peer Reviewers in 2022 for the <i>Journal of Virology</i>.J Virol2022
35947614Host translesion polymerases are required for viral genome integrity.Proc Natl Acad Sci U S A2022
33177198CD34<sup>+</sup> Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.J Virol2021
33653889What Is the Price of Science?mBio2021
33762413Cell type-specific biogenesis of novel vesicles containing viral products in human cytomegalovirus infection.J Virol2021
33811059Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells.Sci Immunol2021
33555583Human Hematopoietic Long-Term Culture (hLTC) for Human Cytomegalovirus Latency and Reactivation.Methods Mol Biol2021
34025614Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.Front Microbiol2021
32268565Human Cytomegalovirus Infection Suppresses CD34<sup>+</sup> Progenitor Cell Engraftment in Humanized Mice.Microorganisms2020
33072616Control of Immediate Early Gene Expression for Human Cytomegalovirus Reactivation.Front Cell Infect Microbiol2020
32632017A molecular mechanism for probabilistic bet hedging and its role in viral latency.Proc Natl Acad Sci U S A2020
32630219The Role of the Human Cytomegalovirus <i>UL133-UL138</i> Gene Locus in Latency and Reactivation.Viruses2020
32759334Human Cytomegalovirus miR-US5-2 Downregulation of GAB1 Regulates Cellular Proliferation and <i>UL138</i> Expression through Modulation of Epidermal Growth Factor Receptor Signaling Pathways.mSphere2020
32694203FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivation.Proc Natl Acad Sci U S A2020
32184335Erratum for Rak et al., "Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency".J Virol2020
31409717Alternative promoters drive human cytomegalovirus reactivation from latency.Proc Natl Acad Sci U S A2019
31725811Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency.PLoS Pathog2019
31725809HCMV miR-US22 down-regulation of EGR-1 regulates CD34+ hematopoietic progenitor cell proliferation and viral reactivation.PLoS Pathog2019
29895640A Single-Cell Approach to the Elusive Latent Human Cytomegalovirus Transcriptome.mBio2018
30127257Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation.Viruses2018
30042195Virus Control of Trafficking from Sorting Endosomes.mBio2018
30089695Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.J Virol2018
27974567Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34<sup>+</sup> Human Progenitor Cells.J Virol2017
28130404Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection.J Exp Med2017
29158406Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency.Proc Natl Acad Sci U S A2017
29250481The loss of binary: Pushing the herpesvirus latency paradigm.Curr Clin Microbiol Rep2017
  • 1 - 50 of 80

Recommended Authors

Nicole L Diggins
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2013
Number of shared co-authors 8
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Danyang Gong
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 1
Thomas J Gardner
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 6
Toni M Schwarz
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 2
Steve Kleiboeker
Eurofins Viracor Clinical Diagnostics
Career Start Year 2008
Number of shared co-authors 0
Jesse H Arbuckle
National Institute of Allergy and Infectious Diseases
Career Start Year 2007
Number of shared co-authors 0
Travis J Chapa
David Geffen School of Medicine, University of California los angeles
Career Start Year 2006
Number of shared co-authors 0
Lara Manganaro
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year 2005
Number of shared co-authors 5
Eleonora Forte
Northwestern University Feinberg School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Finn Grey
The Roslin Institute, The University of Edinburgh
Career Start Year 2003
Number of shared co-authors 6
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 1
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 9
Armin Baiker
Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University
Career Start Year 1999
Number of shared co-authors 0
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 8
J??rgen Haas
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 0
Jan E Carette
Stanford University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Hongyu Deng
Cancer Research Institute, Central South University
Career Start Year 1995
Number of shared co-authors 1
Laurent Coscoy
University of California Berkeley
Career Start Year 1993
Number of shared co-authors 2
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 5
Melanie Ott
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 6
Domenico Tortorella
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 8
Ren Sun
University of California los angeles
Career Start Year 1992
Number of shared co-authors 5
Vicente Planelles
University of Utah
Career Start Year 1991
Number of shared co-authors 4
Keith R Jerome
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 2
Pavel Sova
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 3
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 1
Peter Ghazal
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 1
William J Britt
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1979
Number of shared co-authors 7
Ulrich H Koszinowski
Max von Pettenkofer-Institute, Ludwig-Maximilians-Universitat Munchen
Career Start Year 1973
Number of shared co-authors 0

Collaborators

Arturo Casadevall
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 13
Jay A Nelson
Oregon Health and Science University
Co-authored papers 12
Jeremy P Kamil
Louisiana State University Health Sciences Center Shreveport
Co-authored papers 11
Patrizia Caposio
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 10
Meaghan H Hancock
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 9
Andrew D Yurochko
Louisiana State University
Co-authored papers 7
Lindsey B Crawford
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 6
Daniel N Streblow
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 5
Andrew Pekosz
Co-authored papers 3
Alexander L Greninger
University of Washington Medical Center
Co-authored papers 3
Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers 3
Britt A Glaunsinger
UC Berkeley
Co-authored papers 3
Janko Nikolich-Zugich
University of Arizona Center on Aging, University of Arizona
Co-authored papers 3
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Stephen P Goff
Columbia University
Co-authored papers 3
Balaji Manicassamy
University of Iowa
Co-authored papers 3
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Michael Emerman
Fred Hutchinson Cancer Center
Co-authored papers 3
Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
Wesley I Sundquist
University of Utah School of Medicine
Co-authored papers 3
Nels C Elde
University of Utah School of Medicine
Co-authored papers 3
Rolf Renne
Co-authored papers 3
Adam S Lauring
University of Michigan ann arbor
Co-authored papers 3
Nicholas S Heaton
Duke University School of Medicine
Co-authored papers 3
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Adrianus C M Boon
Co-authored papers 3
Charles M Rice
Rockefeller University
Co-authored papers 3
Matthew D Weitzman
The Children's Hospital of Philadelphia
Co-authored papers 3
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 3
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Release 1.2